New Zealand markets closed

Pfizer Inc. (0Q1N.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
27.99+0.29 (+1.05%)
As of 07:13PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 156.96B
Enterprise value 213.74B
Trailing P/E N/A
Forward P/E 11.03
PEG ratio (5-yr expected) 0.23
Price/sales (ttm)2.61
Price/book (mrq)1.56
Enterprise value/revenue 3.89
Enterprise value/EBITDA 28.77

Trading information

Stock price history

Beta (5Y monthly) 0.57
52-week change 3-29.25%
S&P500 52-week change 325.51%
52-week high 337.80
52-week low 325.21
50-day moving average 325.42
200-day moving average 327.97

Share statistics

Avg vol (3-month) 398.88k
Avg vol (10-day) 3N/A
Shares outstanding 55.65B
Implied shares outstanding 66.06B
Float 85.64B
% held by insiders 10.04%
% held by institutions 170.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.64
Forward annual dividend yield 45.31%
Trailing annual dividend rate 31.62
Trailing annual dividend yield 35.85%
5-year average dividend yield 43.78
Payout ratio 443.09%
Dividend date 3N/A
Ex-dividend date 408 Nov 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)02 Jul 2023

Profitability

Profit margin 27.55%
Operating margin (ttm)32.53%

Management effectiveness

Return on assets (ttm)7.63%
Return on equity (ttm)23.07%

Income statement

Revenue (ttm)77.94B
Revenue per share (ttm)13.85
Quarterly revenue growth (yoy)-54.10%
Gross profit (ttm)66.23B
EBITDA 31.07B
Net income avi to common (ttm)21.49B
Diluted EPS (ttm)3.76
Quarterly earnings growth (yoy)-76.50%

Balance sheet

Total cash (mrq)44.79B
Total cash per share (mrq)7.93
Total debt (mrq)65.67B
Total debt/equity (mrq)66.14%
Current ratio (mrq)2.12
Book value per share (mrq)17.54

Cash flow statement

Operating cash flow (ttm)14.56B
Levered free cash flow (ttm)12.35B